Bone Regeneration Market Expected to Reach US$ 7,827.8 Million by 2033 at a 3.8% CAGR

Bone Regeneration Market
Bone Regeneration Market

The global bone regeneration market is projected to be valued US$ 5,380.75 million in 2023 and grow at a 3.8% compound annual growth rate to US$ 7,827.8 million by 2033. With a market share of 81.2% in 2022, bone graft substitutes commanded the highest share of any product category.

The need for bone regenerating treatments has increased due to the global frequency of bone disorders and the requirement for reconstructive surgery. According to statistics, approximately 10% of men and 18% of women over 60 have osteoarthritis that is symptomatic. Aside from this, there has been a sharp rise in hip fractures and bone injuries, particularly among athletes, which has raised the need for bone regeneration procedures.

Inform Decisions With a Report Sample:
https://www.futuremarketinsights.com/reports/sample/rep-gb-15486

Multiple Factors Fueling Market Growth:

Several factors are contributing to the growth of the bone regeneration market:

  • Aging Population: The rising global population over 60 is more susceptible to bone diseases like osteoarthritis, leading to a greater need for bone repair procedures. Statistics show a significant portion of this age group experiences osteoarthritis symptoms.
  • Increased Bone Injuries: A growing number of sports injuries and hip fractures, particularly among active individuals, is fueling the demand for bone regeneration surgeries.

Addressing Bone Issues: Bone Regeneration Offers Hope for Restoration

The global bone regeneration market is experiencing steady growth, driven by the rising demand for effective solutions in treating bone injuries, diseases, and deformities. Bone regeneration techniques play a vital role in promoting bone healing and reconstruction, improving patient outcomes and quality of life.

Key Takeaways:

  • The global bone regeneration market is expected to reach US$7,827.8 million by 2033, reflecting a rise from US$5,380.75 million in 2023.
  • This growth is projected at a consistent compound annual growth rate (CAGR) of 3.8% throughout the forecast period.
  • The increasing need for reconstructive surgeries and the growing prevalence of bone diseases are key drivers for market expansion.

Competitive Landscape:

Key competitors in the bone regeneration sector are focusing on collaborations, product launches, and expansion to achieve a dominant position in the market. With the use of these strategies, market participants can increase the number of products they offer and their market penetration. As a result, they have seen a rise in their overall revenue share in the global market for bone regeneration.

Given below are a few examples of the key strategies followed by the manufacturers:

  • In March 2022, Biocomposites, a multinational maker of medical products, and Zimmer Biomet agreed to a multiyear distribution agreement for Genex Bone Graft Substitute in the orthopedic market in the USA This product features a new mixing mechanism and delivery options.
  • In February 2020, Integra LifeSciences launched the AmnioExcel® Plus placental allograft membrane.

Unveil Our Research Methods:
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-15486

Key Players

  • Medtronic plc.
  • Stryker Corporation
  • DePuy Synthes Inc.
  • Integra Lifesciences Holdings Corporation
  • Zimmer Biomet HoldingsInc.
  • Xtant Medical HoldingsInc.
  • Arthrex Inc.
  • Baxter International Inc.
  • Musculoskeletal Transplant Foundation
  • Smith & NephewInc.
  • Orthofix HoldingsInc.
  • NuvasiveInc.
  • Allosaurus
  • NovaBone ProductsLLC
  • BonAlive Biomaterials Ltd.
  • Sigma Graft Biomaterials
  • RTI Surgical
  • Institut Straumann AG
  • ExactechInc
  • A.B. Dental Devices Ltd
  • Geistlich Pharma AG
  • BMT Group
  • Osstem Implant

Key Segments:

By Product:

  • Bone Grafts Substitutes
    • Allografts
      • Demineralized Bone Matrix(DBM)
      • Others
    • Xenograft
    • Autografts
    • Synthetic Bone Graft
    • Bone Morphogenetic Protein(BMP)
  • Bone Growth Stimulators
    • Non-Invasive Electrical Bone Growth Stimulators
    • Invasive Electrical Bone Growth Stimulators

By Application:

  • Osteoarthritis (OA)
  • Osteoporosis
  • Rheumatoid Arthritis (RA)
  • Spinal Disorders
  • Dentistry
  • Craniomaxillofacial (CMF)
  • Trauma Cases

By Age Group:

  • Pediatric
  • Adults
  • Geriatric

By End User:

  • Hospitals
  • Orthopedic Clinics
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

In-Depth Market Analysis: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/15486

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Leave a comment

Your email address will not be published. Required fields are marked *